Seres Therapeutics
MCRB
MCRB
36 hedge funds and large institutions have $36.4M invested in Seres Therapeutics in 2025 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.71% more ownership
Funds ownership: 24.28% → 26.99% (+2.7%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less capital invested
Capital invested by funds: $40.9M → $36.4M (-$4.53M)
Holders
36
Holding in Top 10
1
Calls
$6.72M
Puts
$2.33M
Top Buyers
| 1 | +$3.14M | |
| 2 | +$912K | |
| 3 | +$449K | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$284K |
| 5 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
+$251K |
Top Sellers
| 1 | -$519K | |
| 2 | -$147K | |
| 3 | -$94.6K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$89.8K |
| 5 |
Citigroup
New York
|
-$50.4K |
